Moreover, NF-κB activation, inducing pro-inflammatory transcription, has been described in DM1 muscle cell [136] and DM1 glial cell [138] models, suggesting that NF-κB might increase SASP in DM. Here, NFKB1 is linked to diabetes mellitus.